Skip to main content

Berinert 500 IU injectable

Prescription request online

Prescription request online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

Doctor
5.0(6)

Jorge Correa Bellido

General medicine7 years of experience
Licence no. 464626297

Dr. Jorge Correa Bellido is a Spanish physician who offers online consultations in Spanish and English. He graduated from the University of La Laguna and has a solid background in clinical practice and international research.

Throughout his career, he has participated in various medical and academic projects, including a research fellowship in Spain, where he contributed to evidence-based studies in the field of family medicine. This experience allowed him to broaden his global perspective on healthcare and comprehensive patient care.

Dr. Correa Bellido has worked with several healthcare providers in Spain, focusing particularly on patient-centered care and public health initiatives aimed at communities with limited access to healthcare services.

In addition, he actively participates in international medical conferences and workshops, which allows him to stay up to date with the latest medical advances and collaborate with healthcare professionals from different countries.

Dr. Correa Bellido provides comprehensive care for a wide variety of medical conditions, including:

  • respiratory infections
  • gastrointestinal disorders
  • cardiovascular problems
  • endocrine and metabolic diseases
  • musculoskeletal and dermatological conditions
  • as well as mental health conditions such as anxiety and depression.

He also treats infectious and allergic diseases, general health concerns, and provides guidance on prevention and healthy lifestyle habits.

His services include virtual consultations, diagnosis and management of acute and chronic diseases, prescription renewals, and personalized medical advice.

With a patient-centered approach and a strong commitment to continuous learning, Dr. Correa Bellido provides accessible and high-quality healthcare to patients both in Spain and around the world.

Book a video appointment
€86
This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use BERINERT 500 IU POWDER AND SOLVENT FOR INJECTION AND INFUSION SOLUTION

Contents of the leaflet

  1. Introduction
  2. What is Berinert and what is it used for
  3. What you need to know before you use Berinert
  4. How to use Berinert
  5. Possible side effects
  6. Storage of Berinert
  7. Container contents and additional information

Introduction

Package Leaflet: Information for the User

Berinert 500 UI

Powder and solvent for solution for injection and infusion.

Human C1 esterase inhibitor

Read all of this leaflet carefully before you start using this medicine.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
  • If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

  1. What is Berinert and what is it used for
  2. What you need to know before you use Berinert
  3. How to use Berinert
  4. Possible side effects
  5. Storage of Berinert
  6. Contents of the pack and other information

1. What is Berinert and what is it used for

What is Berinert?

Berinert is presented as a powder and solvent. The prepared solution is to be administered by injection or infusion into a vein.

Berinert is prepared from human plasma (the liquid part of the blood), the active substance is human C1 esterase inhibitor protein, obtained from plasma.

What is Berinert used for?

Berinert is used for the treatment and preoperative prevention of hereditary angioedema type I and II (HAE, edema = swelling). Hereditary angioedema is a congenital vascular system disease. HAE is not an allergic disease. HAE is caused by insufficient, absent, or defective synthesis of the C1 esterase inhibitor, which is an important protein. The disease is characterized by the following symptoms:

  • sudden swelling of hands and feet,
  • sudden swelling of the face with a feeling of tightness,
  • swelling of the eyelids, lips, possible swelling of the larynx (voice organ) with breathing difficulties,
  • swelling of the tongue,
  • colic-like pain in the abdominal region.

Generally, all parts of the body can be affected.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you use Berinert

The following sections contain information that your doctor should consider before administering Berinert to you.

Do not use Berinert:

  • If you are allergic to C1 esterase inhibitor or to any of the other components of this medicine (listed in section 6).

Tell your doctor or pharmacist if you are allergic to any medicine or food.

Warnings and precautions

  • If you have suffered allergic reactions to Berinert in the past. You should take antihistamines and corticosteroids as prophylaxis, if advised by your doctor.
  • When allergic reactions or anaphylactic reactions (severe allergic reaction causing severe breathing difficulties or dizziness) occur. Berinert administration should be interrupted immediately (e.g., by interrupting the infusion).
  • If you suffer from laryngeal swelling (laryngeal edema). You should be closely monitored and have emergency treatment ready for use.
  • During use for the treatment of indications and dosages for which the medicine has not been approved (e.g., Capillary Leak Syndrome,CLS). See section 4 "Possible side effects".

Your doctor will carefully weigh the benefit of treatment with Berinert against the risk of these complications.

Viral safety

When administering medicines derived from human blood or plasma, certain measures must be taken to prevent infections from being passed on to patients. These measures include:

  • careful selection of blood and plasma donors to exclude those who are at risk of being carriers of infectious diseases, and
  • testing for specific virus and infection markers in individual donations and plasma pools,

Manufacturers of these products also include stages in the processing of blood or plasma to eliminate or inactivate viruses. Despite this, when administering medicines derived from human blood or plasma, the possibility of transmitting infectious agents cannot be entirely excluded. This also applies to emerging or unknown viruses or other types of infections.

The measures taken are considered effective for enveloped viruses such as human immunodeficiency virus (HIV, the AIDS virus), hepatitis B virus, hepatitis C virus (inflammation of the liver), and for non-enveloped viruses such as hepatitis A virus (inflammation of the liver) and parvovirus B19.

It is possible that your doctor may recommend vaccination against hepatitis A and B if you are treated periodically/repeatedly with human plasma-derived medicines.

It is strongly recommended that each time Berinert is administered, your doctor records the date of administration, batch number, and volume injected.

Using Berinert with other medicines

  • Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines, including those without a prescription.
  • Berinert must not be mixed with other medicines and diluents in the same syringe or infusion equipment.

Pregnancy and breastfeeding

  • If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
  • During pregnancy and breastfeeding, Berinert should only be used if clearly indicated.

Driving and using machines

The influence of Berinert on the ability to drive and use machines is negligible.

Berinert contains sodium

Berinert contains up to 49 mg of sodium (main component of cooking/table salt) per vial. This is equivalent to 2.5% of the maximum recommended daily sodium intake for an adult.

3. How to use Berinert

Treatment should be initiated and supervised by a doctor with experience in the treatment of C1 esterase inhibitor deficiency.

Dosage

Adults

Treatment of acute angioedema attacks:

20 UI per kilogram of body weight (20 UI/kg body weight).

Preoperative prevention of acute angioedema attacks:

1000 UI before 6 hours of a medical, dental, or surgical procedure.

Pediatric population

Treatment of acute angioedema attacks:

20 UI per kilogram of body weight (20 UI/kg body weight).

Preoperative prevention of acute angioedema attacks:

15 to 30 UI per kilogram of body weight (15-30 UI/kg body weight) before 6 hours of a medical, dental, or surgical procedure. The dose should be chosen taking into account the clinical circumstances (e.g., the type of procedure and the severity of the disease).

If you use more Berinert than you should

There have been no reports of overdose.

Reconstitution and method of administration

Berinert is injected into a vein (intravenous administration), usually by your doctor or nurse. You or your caregiver can also inject Berinert, but only after receiving adequate training. If your doctor decides that you can treat yourself at home, they will give you detailed instructions. You will be given a diary to record each injection administered at home, which you should bring with you each time you visit the doctor. You or your caregiver will be regularly reviewed to ensure that you are administering the injections correctly over time.

General instructions

  • The powder must be dissolved and withdrawn from the vial under aseptic conditions. Use the syringe provided with the product.
  • The prepared solution must be clear and transparent. After filtering or transferring the solution (see below), it should be visually checked for particles or discoloration before administration.
  • Do not use the solution if it is visibly cloudy or contains particles or residues.
  • Any unused medicine or material should be disposed of according to local regulations and your doctor's instructions.

Reconstitution

Before opening any vial, allow the Berinert powder and solvent to reach room temperature. To do this, you can leave the vials at room temperature for about an hour or hold them in your closed hands for a few minutes. DO NOT expose the vials to direct heat. The vials should not be heated to a temperature above body temperature (37°C).

Carefully remove the protective caps from the solvent vial and the powder vial. Clean the exposed rubber stoppers of both vials with an alcohol-impregnated swab and let them dry. You can now transfer the solvent to the powder vial using the included administration system (Mix2Vial). Please follow the instructions below:

Cylindrical white protective cap with slots and a slightly widened base for placement 1

  1. Open the Mix2Vial blister by tearing off the seal. Do not remove the Mix2Vial from the blister.

Transparent vial with stopper and white plunger pressing down indicated by a black arrow 2

  1. Place the solvent vial on a clean, flat surface and hold it firmly. Hold the Mix2Vial along with the blister and push the blue terminal down onto the solvent vial stopper.

Pre-filled syringe with retracted plunger showing dose scale and transparent protective cap 3

  1. Carefully remove the blister from the Mix2Vial by holding the edge and pulling vertically upwards. Make sure you only remove the blister and not the Mix2Vial.

Set of stacked cylindrical components with a small black cap to the side 4

  1. Place the powder vial on a flat, firm surface. Invert the solvent vial with the Mix2Vial attached and push the transparent adapter terminal down onto the powder vial stopper. The solvent will automatically transfer to the powder vial.

Two stacked cylinders with a connector in the middle and a curved arrow indicating rotation 5

  1. Hold the vial with the attached Mix2Vial in one hand and the solvent vial in the other. Carefully unscrew the system, separating it into two parts.

Discard the solvent vial with the blue Mix2Vial adapter attached.

Medicine vial with screw cap and arrow indicating direction of agitation for reconstitution 6

  1. Subject the reconstituted solution vial with the attached transparent adapter to gentle rotational movements until the substance is completely dissolved. Do not shake.

Auto-injector device with transparent cartridge and upper and lower protective mouthpiece 7

  1. Fill an empty, sterile syringe with air. Use the syringe provided with the product. Holding the solution vial vertically, connect the syringe to the Luer Lock adapter of the Mix2Vial. Inject the air into the solution vial.

Transfer of the reconstituted solution to the syringe and administration

8

  1. Holding the syringe plunger down, invert the system and slowly draw the solution into the syringe by pulling the plunger back.

9

  1. Once the solution has been transferred to the syringe, firmly hold the syringe body (keeping the plunger down) and disconnect the transparent Mix2Vial adapter from the syringe.

Administration

The solution should be administered intravenously (i.v.) slowly, either by injection or infusion (4 ml/minute).

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Immediately contact your doctor

  • if you experience any side effect or
  • if you notice any side effect not mentioned in this leaflet.

Side effects with Berinert are rare.

The following side effects have been observed rarely (between 1 and 10 in 10,000 people/patients):

? There is an increased risk of thrombosis (blood clot formation) in attempts to treat or prevent Capillary Leak Syndrome (CLS), e.g., during and after cardiac surgery with extracorporeal circulation. See section 2 "Warnings and precautions".

  • Increased body temperature, as well as burning and itching at the injection site.
  • Hypersensitivity or allergic reactions (such as irregular heartbeat, rapid heartbeat, decreased blood pressure, skin redness, rash, breathing difficulties, headache, dizziness, feeling sick).

In very rare cases (less than 1 in 10,000 patients/people or isolated cases), allergic reactions can lead to shock.

Reporting of side effects

If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Berinert

  • Keep this medicine out of the sight and reach of children.
  • Do not use Berinert after the expiry date, which is stated on the label and carton.
  • Do not store above 30°C.
  • Do not freeze.
  • Keep the container in the outer carton to protect from light.
  • Berinert does not contain preservatives, so the prepared solution should be used immediately.
  • If the prepared solution is not administered immediately, it should be used within 8 hours. The reconstituted product should only be stored in the vial.

6. Container contents and additional information

Berinert composition

The active ingredient is:

Human C1 esterase inhibitor (500 IU/vial; after reconstitution: 50 IU/ml)

For more information, see the section "This information is intended only for healthcare professionals".

The other components are:

Glycine, sodium chloride, sodium citrate.

Consult the last paragraph of section 2. "Berinert contains sodium".

Solvent:water for injectable preparations.

Appearance of the product and container contents

Berinert is presented as a white powder and is supplied with water for injectable preparations as a solvent.

The prepared solution must be transparent and clear.

Presentation

Box with 500 IU contains:

1 vial with powder (500 IU)

1 vial with 10 ml of water for injectable preparations

1 transfer device with 20/20 filter

Administration equipment (inner box):

1 single-use 10 ml syringe

1 venipuncture device

2 alcohol swabs

1 dressing

Marketing authorization holder and manufacturer

CSL Behring GmbH

Emil von Behring Strasse, 76

35041 Marburg, Germany

You can request more information about this medication by contacting the local representative of the marketing authorization holder:

CSL Behring S.A.

c/ Tarragona 157, 18th floor

08014 Barcelona

Spain

This medication is authorized in the member states of the European Economic Areaand in the United Kingdom (Northern Ireland)with the following names:

Berinert 500 IU Powder and solvent for solution for injection/infusion Austria

Berinert 500 Belgium, Cyprus, Germany, Greece, Luxembourg, Poland, Portugal

Berinert 500, 500 IU Powder and solvent for solution for injection/infusion Bulgaria

Berinert 500 IU Czech Republic, Slovakia

Berinert Denmark, Italy

Berinert 500 IU, powder and solvent for injectable/perfusion solution Finland

Berinert 500 IU, powder and solvent for injectable/perfusion solution France

Berinert 500 NE powder and solvent for injectable or infusion solution Hungary

Berinert 500 IU powder and liquid for injection/infusion solution, solution Norway

Berinert 500 IU, powder and solvent for injectable/perfusion solution Romania

Berinert 500 i.e. powder and vehicle for injection or infusion solution Slovenia

Berinert 500 UI Powder and solvent for injectable and perfusion solution Spain

Berinert 500 IE, powder and liquid for injection/infusion solution, solution Sweden

Berinert 500 UI powder and solvent for solution for injection/infusion United Kingdom

Date of the last revision of this prospectus:October 2021

Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es

Thisinformation is intended only for healthcare professionals

QUALITATIVE AND QUANTITATIVE COMPOSITION

The potency of the human C1 esterase inhibitor is expressed in International Units (IU), which is related to the current WHO standard for C1 esterase inhibitor products.

Online doctors for BERINERT 500 IU POWDER AND SOLVENT FOR INJECTION AND INFUSION SOLUTION

Discuss questions about BERINERT 500 IU POWDER AND SOLVENT FOR INJECTION AND INFUSION SOLUTION, including use, safety considerations and whether a prescription is appropriate, subject to medical assessment and local regulations.

Doctor
5.0(6)

Jorge Correa Bellido

General medicine7 years of experience
Licence no. 464626297

Dr. Jorge Correa Bellido is a Spanish physician who offers online consultations in Spanish and English. He graduated from the University of La Laguna and has a solid background in clinical practice and international research.

Throughout his career, he has participated in various medical and academic projects, including a research fellowship in Spain, where he contributed to evidence-based studies in the field of family medicine. This experience allowed him to broaden his global perspective on healthcare and comprehensive patient care.

Dr. Correa Bellido has worked with several healthcare providers in Spain, focusing particularly on patient-centered care and public health initiatives aimed at communities with limited access to healthcare services.

In addition, he actively participates in international medical conferences and workshops, which allows him to stay up to date with the latest medical advances and collaborate with healthcare professionals from different countries.

Dr. Correa Bellido provides comprehensive care for a wide variety of medical conditions, including:

  • respiratory infections
  • gastrointestinal disorders
  • cardiovascular problems
  • endocrine and metabolic diseases
  • musculoskeletal and dermatological conditions
  • as well as mental health conditions such as anxiety and depression.

He also treats infectious and allergic diseases, general health concerns, and provides guidance on prevention and healthy lifestyle habits.

His services include virtual consultations, diagnosis and management of acute and chronic diseases, prescription renewals, and personalized medical advice.

With a patient-centered approach and a strong commitment to continuous learning, Dr. Correa Bellido provides accessible and high-quality healthcare to patients both in Spain and around the world.

Book a video appointment
€86
Doctor
5.0(21)

Nuno Tavares Lopes

General medicine18 years of experience

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies

  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management

  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses

  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment

  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance

  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis

  • Pain management: acute and chronic pain, post-surgical care

  • Public health: prevention, health screenings, long-term monitoring

  • Sick leave (Baixa médica) connected to Segurança Social in Portugal

  • IMT medical certificates for driving licence exchange

Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Book a video appointment
€70
Doctor

Hocine Lokchiri

General medicine21 years of experience

Dr. Hocine Lokchiri is a French consultant with over 20 years of experience in General and Emergency Medicine. He works with adults and children, helping patients with urgent symptoms, infections, sudden health changes and everyday medical concerns that require timely evaluation. His background includes clinical practice in France, Switzerland and the United Arab Emirates, which allows him to navigate different healthcare systems and manage a wide range of conditions with confidence. Patients value his calm, structured approach, clear explanations and evidence-based decision-making.

Online consultations with Dr. Lokchiri are suitable for many situations when someone needs quick medical guidance, reassurance or a clear next step. Common reasons for booking include:

  • fever, chills, fatigue and viral symptoms
  • cough, sore throat, nasal congestion, breathing discomfort
  • bronchitis and mild asthma flare-ups
  • nausea, diarrhoea, abdominal pain, digestive infections
  • rashes, allergic reactions, redness, insect bites
  • muscle or joint pain, mild injuries, sprains
  • headache, dizziness, migraine symptoms
  • stress-related symptoms, sleep disturbances
  • questions about test results and treatment plans
  • management of chronic conditions in stable phases
Many patients reach out when symptoms appear suddenly and cause concern, when a child becomes unwell unexpectedly, when a rash changes or spreads, or when it’s unclear whether an in-person examination is necessary. His emergency medicine background is particularly valuable online, helping patients understand risk levels, identify warning signs and choose safe next steps.

Some situations are not suitable for online care. If a patient has loss of consciousness, severe chest pain, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack, he will advise seeking immediate local emergency services. This improves safety and ensures patients receive the right level of care.

Dr. Lokchiri’s professional training includes:

  • Advanced Trauma Life Support (ATLS)
  • Basic and Advanced Cardiac Life Support (BLS/ACLS)
  • Pediatric Advanced Life Support (PALS)
  • Prehospital Trauma Life Support (PHTLS)
  • eFAST and critical care transthoracic echocardiography
  • aviation medicine
He is an active member of several professional organisations, including the French Society of Emergency Medicine (SFMU), the French Association for Emergency Physicians (AMUF) and the Swiss Society of Emergency and Rescue Medicine (SGNOR). In consultations, he works with clarity and precision, helping patients understand their symptoms, possible risks and the safest treatment options.
Book a video appointment
€64
Doctor
4.7(11)

Anastasiia Shalko

General medicine13 years of experience
Licence no. 52891

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate

Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Book a video appointment
€56
Doctor
5.0(1)

Cristina Andrada Brazo

General medicineSleep medicine16 years of experience
Licence no. 264505958

Dr. Cristina Andrada Brazo is a highly experienced Spanish physician with more than 15 years of clinical practice in emergency medicine, urgent care, and clinical neurophysiology. She provides professional online medical consultations for patients across Spain, helping both residents and international visitors receive timely medical advice, diagnosis, treatment recommendations, and electronic prescriptions when clinically appropriate.

As a licensed physician fully integrated with the Spanish electronic prescription system, Dr. Andrada can issue legally valid e-prescriptions following a medical assessment during an online consultation. Whether you need help with an acute illness, prescription renewal, neurological symptoms, or travel-related healthcare, she offers convenient, patient-centered medical care without the need to visit a clinic.

Dr. Andrada combines extensive emergency medicine experience with advanced expertise in neurology, epilepsy, sleep medicine, and headache disorders. Her international clinical background includes several years working in Switzerland, where she collaborated with multidisciplinary teams in emergency departments and neurology services. This experience strengthened her commitment to evidence-based medicine, compassionate communication, and high-quality patient care.

She graduated in Medicine from the University of Seville and completed her residency in Clinical Neurophysiology at Hospital Virgen de la Salud and the National Hospital for Paraplegics in Toledo. She currently works as a Clinical Neurophysiology Specialist at Hospital San Pedro in Logroño.

To further expand her expertise, Dr. Andrada completed several postgraduate qualifications, including Master's degrees in Sleep Physiology and Medicine, Medical Professionalism and Clinical Practice, Epilepsy, and Clinical Management.

Patients appreciate her thorough consultations, practical treatment recommendations, and empathetic approach. She speaks Spanish, French, and Portuguese, allowing her to communicate comfortably with patients from different backgrounds.

Conditions Dr. Cristina Andrada Treats Online

Dr. Andrada provides online consultations for a wide range of common medical conditions, including:

  • Fever, flu, COVID-19 symptoms, sore throat and respiratory infections
  • Sinusitis, bronchitis, cough and seasonal allergies
  • Urinary tract infections (UTIs)
  • Migraine and tension headaches
  • Dizziness and vertigo
  • Epilepsy and seizure follow-up
  • Sleep disorders, including insomnia and circadian rhythm disturbances
  • Heartburn, gastritis, diarrhea and constipation
  • Back pain, muscle injuries and joint pain
  • Minor skin infections and allergic reactions
  • Fatigue and general medical assessment
  • Prescription renewals for appropriate chronic treatments
  • Follow-up consultations after surgery or previous medical treatment
  • Travel medicine advice and preventive healthcare
  • Interpretation of laboratory results and medical reports

If your condition requires urgent in-person assessment or emergency care, Dr. Andrada will advise you on the most appropriate next steps.

Book an Online Consultation

Book a secure online consultation with Dr. Cristina Andrada Brazo through Oladoctor and receive professional medical advice from an experienced Spanish physician without leaving home. Online appointments are available for adults throughout Spain, with fast access to medical care and electronic prescriptions whenever clinically indicated.

Book a video appointment
€56
Doctor
5.0(8)

Lizaveta Trafimchuk Takhvaniuk

DermatologyGeneral medicine10 years of experience
Licence no. 58788

Dr. Lizaveta Trafimchuk Takhvaniuk graduated in Medicine and subsequently specialized in Dermatology and Venereology. She has more than 10 years of clinical experience and is licensed to practice in Spain, where she focuses on the comprehensive diagnosis and treatment of dermatological conditions.

Throughout her education and professional career, Dr. Trafimchuk has gained extensive experience in managing diseases of the skin, hair, and nails, as well as in the diagnosis, treatment, and prevention of sexually transmitted infections (STIs). Her clinical approach is based on evidence-based medicine, combined with personalized care tailored to each patient’s needs.

In her daily practice, she treats a wide range of dermatological conditions, including chronic inflammatory dermatoses such as acne, rosacea, atopic dermatitis, psoriasis, and eczema. She also has experience in treating pigmentation disorders, including melasma, post-inflammatory hyperpigmentation, and dyschromia.

She has developed a particular interest in trichology, treating various types of alopecia, chronic hair loss, and scalp disorders. In addition, she has experience in managing infectious dermatoses of fungal, viral, and bacterial origin, as well as in evaluating benign and suspicious skin lesions, with referral to specialized care when necessary.

With a strong interest in a comprehensive approach to skin health, she also treats scars, post-procedural skin changes, and conditions related to hormonal factors and aging, including those associated with pregnancy, menopause, and age-related skin changes.

Thanks to her experience and continuous professional development, Dr. Trafimchuk provides high-quality medical care that is professional, confidential, and aligned with modern dermatology standards.

Book a video appointment
€72

Frequently Asked Questions

BERINERT 500 IU POWDER AND SOLVENT FOR INJECTION AND INFUSION SOLUTION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.

The active ingredient in BERINERT 500 IU POWDER AND SOLVENT FOR INJECTION AND INFUSION SOLUTION is c1-inhibitor, plasma derived. This information helps identify medicines with the same composition but different brand names.

BERINERT 500 IU POWDER AND SOLVENT FOR INJECTION AND INFUSION SOLUTION is manufactured by Csl Behring Gmbh. Pharmacy brands and packaging may differ depending on the distributor.

Doctors such as Family doctors, Cardiologists, Nephrologists, Hematologists, General surgeons, General medicine doctors, Phlebologists may assess whether BERINERT 500 IU POWDER AND SOLVENT FOR INJECTION AND INFUSION SOLUTION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.

The prescription is issued by a doctor after assessing your health. In Spain, BERINERT 500 IU POWDER AND SOLVENT FOR INJECTION AND INFUSION SOLUTION is then dispensed in pharmacies with that prescription. An online consultation does not guarantee that a prescription will be issued: the decision always rests with the doctor.

To request an assessment, you can use Oladoctor:

Other medicines with the same active substance (c1-inhibitor, plasma derived) include BERINERT 1500 IU POWDER AND SOLVENT FOR INJECTABLE SOLUTION, BERINERT 2000 IU POWDER AND SOLVENT FOR SUBCUTANEOUS INJECTION SOLUTION, BERINERT 3000 IU POWDER AND SOLVENT FOR SUBCUTANEOUS INJECTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media